A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an exciting new treatment.

Biotechnology is the exploitation of biological processes for the development of technologies and products for a specific use. GlobalData’s Strategic Intelligence report on biotech details how recent ...

A surge in deals and financings had the industry abuzz heading into this year’s J.P. Morgan Healthcare Conference. But some ...

This session examines Saudi Arabia’s value proposition as a regional manufacturing hub for healthcare and medical ...

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $10.48 / share. This is a decrease ...